Home | Archives | Products | About | Contact | FAQ |
New User? Sign Up | Sign In
insider trading reports Form 4 Filings Insider Buys Significant Buys Penny Stocks
Insider Buying
Insider Sales
Insider Buy Sell Ratios Stock Options Insider Trading
Stock Screener
Insider Trading
Graph View
Insider Watch

Insider Trading - Collier Alan Brian

Select Time period:

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Trading Transactions for Collier Alan Brian

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2019-04-10
Purchase
2019-04-12
4:30 pm
ENDONOVO THERAPEUTICS Inc ENDV Collier Alan Brian
CEO
13,500 $0.01705 $230 21,015,124
(Direct)
View
2019-03-27
Purchase
2019-04-04
4:45 pm
ENDONOVO THERAPEUTICS Inc ENDV Collier Alan Brian
CEO
36,000 $0.01756 $632 22,001,624
(Direct)
View
2019-03-25
Purchase
2019-03-28
4:43 pm
ENDONOVO THERAPEUTICS Inc ENDV Collier Alan Brian
CEO
54,000 $0.01821 $983 26,959,624
(Direct)
View
2019-03-19
Purchase
2019-03-22
3:38 pm
ENDONOVO THERAPEUTICS Inc ENDV Collier Alan Brian
CEO
43,000 $0.01922 $827 21,911,624
(Direct)
View
2019-03-13
Purchase
2019-03-20
4:45 pm
ENDONOVO THERAPEUTICS Inc ENDV Collier Alan Brian
CEO
54,500 $0.02016 $1,099 21,868,624
(Direct)
View
2019-03-08
Purchase
2019-03-14
5:00 pm
ENDONOVO THERAPEUTICS Inc ENDV Collier Alan Brian
CEO
21,000 $0.01967 $413 21,814,124
(Direct)
View
2019-03-05
Purchase
2019-03-08
2:53 pm
ENDONOVO THERAPEUTICS Inc ENDV Collier Alan Brian
CEO
103,500 $0.01971 $2,040 21,793,124
(Direct)
View
2019-02-27
Purchase
2019-03-06
4:41 pm
ENDONOVO THERAPEUTICS Inc ENDV Collier Alan Brian
CEO
46,500 $0.02077 $966 21,689,624
(Direct)
View
2019-02-22
Purchase
2019-02-27
4:17 pm
ENDONOVO THERAPEUTICS Inc ENDV Collier Alan Brian
CEO
40,000 $0.02223 $889 21,643,124
(Direct)
View
2019-02-19
Purchase
2019-02-25
5:16 pm
ENDONOVO THERAPEUTICS Inc ENDV Collier Alan Brian
CEO
50,000 $0.02318 $1,159 21,603,124
(Direct)
View
2019-02-15
Purchase
2019-02-21
10:54 am
ENDONOVO THERAPEUTICS Inc ENDV Collier Alan Brian
CEO
17,000 $0.02288 $389 21,553,124
(Direct)
View
2019-02-14
Purchase
2019-02-21
10:43 am
ENDONOVO THERAPEUTICS Inc ENDV Collier Alan Brian
CEO
174,000 $0.0226 $3,932 21,536,124
(Direct)
View
2019-02-12
Purchase
2019-02-15
09:40 am
ENDONOVO THERAPEUTICS Inc ENDV Collier Alan Brian
CEO
17,500 $0.0223 $390 21,362,124
(Direct)
View
2019-02-12
Purchase
2019-02-15
09:36 am
ENDONOVO THERAPEUTICS Inc ENDV Collier Alan Brian
CEO
213,000 $0.02257 $4,806 21,344,624
(Direct)
View
2019-02-06
Purchase
2019-02-11
4:49 pm
ENDONOVO THERAPEUTICS Inc ENDV Collier Alan Brian
CEO
38,000 $0.02592 $985 21,131,624
(Direct)
View
2019-01-30
Purchase
2019-02-05
5:15 pm
ENDONOVO THERAPEUTICS Inc ENDV Collier Alan Brian
CEO
46,000 $0.02583 $1,188 21,093,624
(Direct)
View
2019-01-28
Purchase
2019-01-31
5:50 pm
ENDONOVO THERAPEUTICS Inc ENDV Collier Alan Brian
CEO
59,000 $0.02875 $1,696 21,052,624
(Direct)
View
2019-01-22
Purchase
2019-01-29
4:53 pm
ENDONOVO THERAPEUTICS Inc ENDV Collier Alan Brian
CEO
120,500 $0.02744 $3,306 20,993,624
(Direct)
View
2019-01-17
Purchase
2019-01-23
3:30 pm
ENDONOVO THERAPEUTICS Inc ENDV Collier Alan Brian
CEO
65,500 $0.02708 $1,774 20,873,124
(Direct)
View
2019-01-15
Purchase
2019-01-18
5:22 pm
ENDONOVO THERAPEUTICS Inc ENDV Collier Alan Brian
CEO
161,500 $0.03131 $5,056 20,807,624
(Direct)
View
2019-01-14
Purchase
2019-01-15
5:29 pm
ENDONOVO THERAPEUTICS Inc ENDV Collier Alan Brian
CEO
45,000 $0.03304 $1,487 20,646,124
(Direct)
View
2015-06-15
Purchase(A)
2019-01-14
3:09 pm
ENDONOVO THERAPEUTICS Inc ENDV Collier Alan Brian
CEO
20,601,122 $4.136e-05 $852 20,601,124
(Indirect
Direct)
View
2016-06-20
Purchase
2019-01-14
12:19 pm
ENDONOVO THERAPEUTICS Inc ENDV Collier Alan Brian
CEO
1,045,000 $0.0008153 $852 20,271,656
(Direct)
View
(A) Indicate amendment filing.